Provided By GlobeNewswire
Last update: Jun 3, 2025
Châtillon, France, June 03, 2025
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), today announced today the filing of an addendum to the 2024 Universal Registration Document (the “Addendum”) with the French market authority, “Autorité des Marchés Financiers” (“AMF”).
Read more at globenewswire.com9.13
+0.58 (+6.78%)
Find more stocks in the Stock Screener
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.